Literature DB >> 3108058

Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration.

J R Williamson, K Chang, R G Tilton, C Prater, J R Jeffrey, C Weigel, W R Sherman, D M Eades, C Kilo.   

Abstract

125I-labeled albumin permeation (IAP) has been assessed in various tissues in spontaneously diabetic insulin-dependent female BB/W rats and in male Sprague-Dawley rats with severe or mild forms of streptozocin-induced diabetes (SS-D and MS-D, respectively). In BB/W diabetic rats and in rats with SS-D, indices of IAP were significantly increased in tissues and vessels predisposed to diabetic vascular disease in humans, including the eyes (anterior uvea, posterior uvea, and retina), sciatic nerve, aorta, kidney, and new vessels formed after induction of diabetes. No evidence of increased IAP was observed in heart, brain, testes, or skeletal muscle in BB/W or SS-D rats. In MS-D rats, indices of IAP were increased only in the kidney and in new vessels formed after the onset of diabetes. Marked tissue differences were observed in the effects of two structurally different aldose reductase inhibitors (sorbinil and tolrestat) and of castration on diabetes-induced increases in IAP and in tissue levels of polyols in SS-D rats. Both aldose reductase inhibitors and castration completely prevented diabetes-induced increases in IAP in new vessels and in sciatic nerve in BB/W and SS-D rats. Both aldose reductase inhibitors also markedly decreased IAP in the anterior uvea (approximately 85%), posterior uvea (approximately 65-75%), retina (approximately 65-70%), and kidney (approximately 70-100%); castration reduced IAP in the anterior uvea (approximately 55%), kidney (approximately 50%), and retina (approximately 30%) but had no effect on the posterior uvea. The diabetes-induced increases in IAP in the aorta were reduced only slightly (approximately 20%) by aldose reductase inhibitors and castration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108058     DOI: 10.2337/diab.36.7.813

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  42 in total

1.  Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).

Authors:  Shahid P Baba; Jason Hellmann; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

2.  The effect of non-enzymatic glycation of serum proteins on their permeation into peripheral nerve in normal and streptozotocin-diabetic rats.

Authors:  N J Patel; V P Misra; P Dandona; P K Thomas
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

3.  Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.

Authors:  J R Williamson; E Ostrow; D Eades; K Chang; W Allison; C Kilo; W R Sherman
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics.

Authors:  S A Vinores; C Gadegbeku; P A Campochiaro; W R Green
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 5.  Activation of protein kinase C isoforms and its impact on diabetic complications.

Authors:  Pedro Geraldes; George L King
Journal:  Circ Res       Date:  2010-04-30       Impact factor: 17.367

6.  Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes.

Authors:  B Keymeulen; K de Metz; R Cluydts; A Bossuyt; G Somers
Journal:  Eur J Nucl Med       Date:  1996-02

7.  Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues.

Authors:  E M Rocha; L A Wickham; L A da Silveira; K L Krenzer; F S Yu; I Toda; B D Sullivan; D A Sullivan
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

8.  Establishment of a diabetic mouse model with progressive diabetic nephropathy.

Authors:  Akari Inada; Kojiro Nagai; Hidenori Arai; Jun-ichi Miyazaki; Keiko Nomura; Hiroshi Kanamori; Shinya Toyokuni; Yuichiro Yamada; Susan Bonner-Weir; Gordon C Weir; Atsushi Fukatsu; Yutaka Seino
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

9.  Enhanced permeability responses to inflammation in streptozotocin-induced diabetic rat venules: Rho-mediated alterations of actin cytoskeleton and VE-cadherin.

Authors:  Dong Yuan; Sulei Xu; Pingnian He
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

10.  Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat.

Authors:  H G Forster; P M ter Wee; T C Hohman; M Epstein
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.